XML 24 R13.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 1 - Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2017
Notes Tables  
Available-for-sale Securities [Table Text Block]
    June 30, 2017
    Amortized
Cost
  Accrued
Interest
  Gross
Unrealized
Gains
  Gross
Unrealized
Losses
  Estimated
Fair Value
Obligations of the U.S. Government and its agencies   $
26,436
    $
85
    $
    $
(11
)   $
26,510
 
Corporate debt securities    
9,248
     
42
     
1
     
(8
)    
9,283
 
Certificates of deposit    
14,762
     
22
     
9
     
(6
)    
14,787
 
                                         
Total investments   $
50,446
    $
149
    $
10
    $
(25
)   $
50,580
 
    December 31, 2016
    Amortized
Cost
  Accrued
Interest
  Gross
Unrealized
Gains
  Gross
Unrealized
Losses
  Estimated
Fair Value
Obligations of the U.S. Government and its agencies   $
20,266
    $
34
    $
2
    $
(4
)   $
20,298
 
Corporate debt securities    
6,179
     
26
     
2
     
(8
)    
6,199
 
Certificates of deposit    
14,962
     
17
     
7
     
(11
)    
14,975
 
                                         
Total investments   $
41,407
    $
77
    $
11
    $
(23
)   $
41,472
 
Available For Sale Securities Debt Maturities Fair Value [Table Text Block]
    2017   2016
Maturing in one year or less   $
40,977
    $
32,546
 
Maturing after one year through two years    
9,603
     
8,926
 
                 
Total investments   $
50,580
    $
41,472
 
Schedule of Receivables from Collaborations [Table Text Block]
    June 30, 2017
    Billed   Unbilled   Total
U.S. Department of Health and Human Services   $
276
    $
1,630
    $
1,906
 
Shionogi & Co. Ltd.    
107
     
     
107
 
Green Cross Corporation    
359
     
     
359
 
Seqirus UK Limited    
747
     
206
     
953
 
                         
Total receivables   $
1,489
    $
1,836
    $
3,325
 
    December 31, 2016
    Billed   Unbilled   Total
U.S. Department of Health and Human Services   $
    $
3,495
    $
3,495
 
Shionogi & Co. Ltd.    
3,451
     
     
3,451
 
Green Cross Corporation    
686
     
     
686
 
Seqirus UK Limited    
957
     
179
     
1,136
 
                         
Total receivables   $
5,094
    $
3,674
    $
8,768
 
Schedule of Inventory, Current [Table Text Block]
    2017   2016
Work in process   $
1,305
    $
500
 
                 
Inventories   $
1,305
    $
500
 
Schedule of Revenues from Collaborations [Table Text Block]
    Three Months   Six Months
    2017   2016   2017   2016
Royalty revenue   $
489
    $
629
    $
6,810
    $
2,519
 
Collaborative and other research and development revenues:                                
U.S. Department of Health and Human Services    
2,161
     
3,709
     
2,815
     
6,033
 
Shionogi & Co. Ltd.    
296
     
296
     
592
     
592
 
Seqirus UK Limited    
153
     
153
     
2,319
     
463
 
Total collaborative and other research and development revenues    
2,610
     
4,158
     
5,726
     
7,088
 
                                 
Total revenues   $
3,099
    $
4,787
    $
12,536
    $
9,607